ATHENS MEDICAL CENTER S.A.

As of June 30, 2016, ATHENS MEDICAL CENTER S.A. carries a market capitalization of 64.97M, placing it among publicly traded companies globally. Its enterprise value stands at 209.00M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2016, ATHENS MEDICAL CENTER S.A. has 86.74M shares outstanding.

These figures are as of June 30, 2016.

As of June 30, 2016, ATHENS MEDICAL CENTER S.A. maintains a current ratio of 0.48, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2016.

Over the twelve months ended June 30, 2016, ATHENS MEDICAL CENTER S.A. recorded 671,000.00 in income tax expense.

As of the close on October 22, 2026, ATHENS MEDICAL CENTER S.A.'s stock has declined approximately 21.18% over the past 52 weeks. The 50-day moving average sits at 1.53, while the 200-day moving average is 1.73.

As of June 30, 2016, ATHENS MEDICAL CENTER S.A. holds 4.52M in cash and equivalents against 148.40M in total debt, resulting in a net debt position of 143.78M. Total book value stands at 59.85M, with working capital of -142.43M providing operational flexibility.

ATHENS MEDICAL CENTER S.A.'s most recent stock split took place on February 8, 2000 with a 7:17 split ratio.